Catalog No.
VVV24002
Species reactivity
Influenza A virus (strain A/Japan/305/1957 H2N2) (Q1K9Q1), Influenza A virus (strain A/RI/5-/1957 H2N2) (P03484)
Host species
Human
Isotype
IgG1
Clonality
Monoclonal
Target
Neuraminidase, 3.2.1.18, NA
Concentration
0.9 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q1K9Q1
Applications
ELISA, Neutralization
Form
Liquid
Storage buffer
100 mM Pro-Ac, 20 mM Arg, pH 5.0
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
1E01#
Morphology-dependent entry kinetics and spread of influenza A virus., PMID:40490555
No indication of highly pathogenic avian influenza infections in Dutch cows., PMID:40458141
Kinetic MUNANA assay reveals functionally relevant antibody epitopes on Influenza A virus neuraminidase., PMID:40348878
Identification & genetic & virological characterisation of a human case of avian influenza A (H9N2) virus from Eastern India., PMID:40347502
Synthetic Neuraminidase Vaccine Induces Cross-Species and Multi-Subtype Protection., PMID:40333263
Seroprevalence of anti-influenza antibodies in humans and characterization of seasonal influenza viruses isolated in Russia during the 2023-2024 flu season., PMID:40307541
Chimeric virus-like particles of nodavirus displaying M2e of human and avian influenza A viruses as a potential dual-use vaccine: Inducing a broader immune response and protecting mice against viral infections., PMID:40286563
Multivalent H3 COBRA-based influenza vaccine elicits enhanced immune response in a pre-immune elderly ferret model., PMID:40267617
Application of Humanized MHC Transgenic Mice in the Screening of HLA-Restricted T Cell Epitopes for Influenza Vaccines., PMID:40266241
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination., PMID:40265888
Influenza A hemagglutinin virus-like particles confer protection against influenza B virus infection., PMID:40230200
A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses., PMID:40193611
Live-attenuated pandemic H1N1 influenza vaccines expressing computationally optimized broadly reactive antigens (COBRAs) are immunogenic and protective in mice and ferrets., PMID:40186991
Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody., PMID:40178595
Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus., PMID:40145257
A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e., PMID:40139072
Drug-Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice., PMID:40097766
Influenza A(H5N1) Immune Response among Ferrets with Influenza A(H1N1)pdm09 Immunity., PMID:40023796
Effect of Prior Influenza A(H1N1)pdm09 Virus Infection on Pathogenesis and Transmission of Human Influenza A(H5N1) Clade 2.3.4.4b Virus in Ferret Model., PMID:40023783
Diagnostic Assays for Avian Influenza Virus Surveillance and Monitoring in Poultry., PMID:40006983
A single dose of inactivated influenza virus vaccine expressing COBRA hemagglutinin elicits broadly-reactive and long-lasting protection., PMID:39982912
Evaluation of an N1 NA antibody-specific enzyme-linked lectin assay for detection of H5N1 highly pathogenic avian influenza virus infection in vaccinated birds., PMID:39956396
Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus., PMID:39879304
A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen., PMID:39852870
Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®., PMID:39798434
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens., PMID:39756216
Comparison of neuraminidase inhibiting antibody responses elicited by egg- and cell-derived influenza vaccines., PMID:39754936
Identification of a broad-inhibition influenza neuraminidase antibody from pre-existing memory B cells., PMID:39740671
Targets of influenza human T-cell response are mostly conserved in H5N1., PMID:39714185
Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections., PMID:39702744
An influenza mRNA vaccine protects ferrets from lethal infection with highly pathogenic avian influenza A(H5N1) virus., PMID:39693411
Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions., PMID:39690742
Detection of antibodies against H5 subtype highly pathogenic avian influenza viruses in multiple raccoons in Tokachi District, Hokkaido, Japan, from 2022 to 2023., PMID:39689812
Cross-neutralization of Influenza A by SARS-CoV-2 specific neutralizing antibodies and polyclonal plasma: Is pre-exposure to SARS-CoV-2 protective against Influenza A?, PMID:39654774
A neuraminidase-based inactivated influenza virus vaccine significantly reduced virus replication and pathology following homologous challenge in swine., PMID:39645432
Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model., PMID:39636110
Highly Pathogenic H5N1 Influenza A Virus (IAV) in Blue-Winged Teal in the Mississippi Flyway Is Following the Historic Seasonal Pattern of Low-Pathogenicity IAV in Ducks., PMID:39599570
Evolutionary analysis of Hemagglutinin and neuraminidase gene variation in H1N1 swine influenza virus from vaccine intervention in China., PMID:39567587
Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2., PMID:39551038
Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy., PMID:39502688
Measures of Population Immunity Can Predict the Dominant Clade of Influenza A (H3N2) in the 2017-2018 Season and Reveal Age-Associated Differences in Susceptibility and Antibody-Binding Specificity., PMID:39501522
Efficacy of the H7N9 vaccine as a candidate for the Korean avian influenza antigen bank., PMID:39486146
SARS-CoV-2 spike-based virus-like particles incorporate influenza H1/N1 antigens and induce dual immunity in mice., PMID:39481241
A human monoclonal antibody targeting the monomeric N6 neuraminidase confers protection against avian H5N6 influenza virus infection., PMID:39402031
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA., PMID:39379405
Antiviral Susceptibility of Swine-Origin Influenza A Viruses Isolated from Humans, United States., PMID:39378870
Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID-19 epidemic in Wuhan, China., PMID:39370830
Broadly cross-reactive immune responses in chickens immunized with chimeric virus-like particles of nodavirus displaying the M2e originated from avian and human influenza A viruses., PMID:39341478
Adjuvant Use of the Invariant-Natural-Killer-T-Cell Agonist α-Galactosylceramide Leads to Vaccine-Associated Enhanced Respiratory Disease in Influenza-Vaccinated Pigs., PMID:39340098
Headless hemagglutinin-containing influenza viral particles direct immune responses toward more conserved epitopes., PMID:39324791
For research use only. Not for human or drug use.
